EMD Serono to Open Site in Cambridge
3 Jun, 2009
EMD Serono , a pharmaceutical company that focuses on neurodegenerative diseases including multiple sclerosis, has recently announced that it will open a site in Cambridge. The laboratory space in Cambridge will accommodate its drug discovery activities and will secure necessary space for additional scientists as a result of accelerated employee growth. The Cambridge satellite laboratory will be approximately 18,000 SF in size and will be occupied by an estimate of 50 scientists.